diabetic retinopathy



Nano One Materials Corp.
Latest Comments
image_pdfimage_print

The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease

Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage disease is […]


Eyes on DIAGNOS as commercialization gains momentum

The best time to buy an emerging company is when it begins commercialization. At this stage all the hard years […]


Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology

CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely […]


Thompson on DIAGNOS and the ‘exploding’ AI healthtech industry

AI Healthcare Provider Diagnos Continues to Sign Deals and Partnerships Amid COVID-19 Crisis Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF […]


Diagnos’ AI Platform to Fight Vision Loss Continues to Expand Globally

Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) is a software platform provider for the early detection of critical health issues […]